LCTX compared with IMDX: revenue, margins and what each company keeps, and the suppliers and customers both name

LCTXLineage Cell Therapeutics, Inc.

Mkt capRevenueRevenue

IMDXInsight Molecular Diagnostics Inc.

Mkt capRevenueRevenue

Compare

LCTXLineage Cell Therapeutics, Inc.

IMDXInsight Molecular Diagnostics Inc.

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closesMethod ›

Moved together

LCTXwithIMDX

No shared trading history for LCTX and IMDX.

Shared co-movers: not yet measured (LCTX, IMDX).

LCTX, solidIMDX, hatchedr = correlationBar = r to r 0.75Source: daily closes

LCTXLineage Cell Therapeutics, Inc.

1.01▼−2.30%· post 1.01

Mkt cap$252.9MRevenue$1MQ2 FY26Revenue$15MFY25

IMDXInsight Molecular Diagnostics Inc.

2.97▼−6.51%· post 2.97

ClosedOct 30 '26

Mkt cap$96.9MRevenue$239,000Q2 FY26Revenue$4MFY25

Compare

ClosedOct 30 '26

LCTXLineage Cell Therapeutics, Inc.

IMDXInsight Molecular Diagnostics Inc.

1.01▼−2.30%post 1.01

Price

2.97▼−6.51%post 2.97

$252.9M

Mkt cap

$96.9M

Q2 FY26$1M

Revenue

$239,000Q2 FY26

FY25$15M

Revenue

$4MFY25

LCTX1.01▼−2.30%vsIMDX2.97▼−6.51%ClosedOct 30 '26